drugset / Trial / NCT01083888

ASP1517 Pharmacokinetics Study in Anemia Patients on Hemodialysis

NCT01083888

Phase 1 Completed 12 enrolled Astellas Pharma Inc
Non-randomizedSingle-groupOpen-labelBasic science

Summary

To assess the Pharmacokinetics and pharmacodynamics of single doses of ASP1517 in renal anemia patients on hemodialysis. Safety and tolerability will be also evaluated in these patients.

Timeline

Start
2010-02-15
Primary completion
2010-06-07
Completion
2010-06-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Roxadustat Small molecule Oral